SynthesisBMC gastroenterology2025
Relationship of D-dimer with survival and metastasis in gastric cancer patients: a meta-analysis and systematic review.
Synthesis in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical features and prognostic factors for spinal metastasis from sarcomatoid carcinoma: identifying candidates suitable for surgical intervention.BMC musculoskeletal disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveD-dimer predicts survival in patients with digestive cancers. However, comprehensive analysis focused on gastric cancer patients is lacking. This meta-analysis aimed to investigate the association of D-dimer with survival in gastric cancer patients.
methodsStudies exploring the relationship of D-dimer with the prognosis of gastric cancer patients were included. Web of Science, PubMed, Cochrane Library, and EMBASE databases were used to identify studies until October 1st, 2024. The methodological index for non-randomized studies (MINORS) tool was used for quality assessment. The Begg's test was applied to evaluate publication bias. Hazard ratio (HR), risk ratio (RR), and 95% confidence interval (CI), were used to calculate the outcomes.
resultsThis meta-analysis contained 10 studies with 4746 gastric cancer patients. High D-dimer level was related to unsatisfactory overall survival (OS) [HR (95% CI): 1.44 (1.27, 1.64), P < 0.001] and disease-free survival (DFS)/progression-free survival (PFS) [HR (95% CI): 1.79 (1.50, 2.13), P < 0.001]. Subgroup analyses disclosed that in studies conducted in China, prospective studies, retrospective studies, studies with a sample size of ≤ median value (335.5), and studies with a sample size of > median value, high D-dimer level was linked to short OS and DFS/PFS (all P < 0.01). The association of D-dimer with OS and DFS/PFS was not found in studies conducted in Korea (both P > 0.05). High D-dimer level was linked to lymph node metastasis [RR (95% CI): 1.37 (1.14, 1.66), P = 0.001]. However, D-dimer was not related to distant metastasis [RR (95% CI): 1.06 (0.76, 1.49), P = 0.718]. No publication bias existed, and the stability of this meta-analysis was acceptable.
conclusionHigh D-dimer level is associated with unsatisfactory survival and lymph node metastasis in gastric cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.